CAMRAS VISION, INC.

Company Information
Address 2 Davis Drive
RTP, NC, 27709-0003

http://www.camrasvision.com

Information

DUNS: 965430908

# of Employees: 5


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Safety and Efficacy of a Titratable External Shunt

    Amount: $350,855.00

    Glaucoma is a diverse group of chronic diseases that causes irreversible damage to the optic nerve and is a leading cause of blindness affecting million people worldwide It is estimated that in ...

    SBIRPhase II2017Department of Health and Human Services National Institutes of Health
  2. SBIR Phase II: Adjustable Eye Pressure Control within an External Shunt

    Amount: $713,172.00

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project allows for a more effective glaucoma treatment by adjusting eye pressure based on disease pro ...

    SBIRPhase II2016National Science Foundation
  3. Safety and Efficacy of a Titratable External Shunt

    Amount: $299,981.00

    Glaucoma is a diverse group of chronic diseases that causes irreversible damage to the optic nerve and is a leading cause of blindness affecting million people worldwide It is estimated that in people ...

    SBIRPhase I2016Department of Health and Human Services
  4. SBIR Phase I:Feasibility of Adjustable Eye Pressure Control within an External Shunt

    Amount: $150,000.00

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project allows for a more effective glaucoma treatment by tailoring eye pressure based on disease prog ...

    SBIRPhase I2015National Science Foundation
  5. SBIR Phase I: Feasibility of The Use of a Debris Cartridge in an External Drainage Device

    Amount: $149,978.00

    This Small Business Innovation Research Phase I project will demonstrate the feasibility of the use of a debris cartridge in an implant to prevent obstruction in debris-releasing glaucomas, such as uv ...

    SBIRPhase I2013National Science Foundation
  6. External Glaucoma Drainage Device

    Amount: $176,270.00

    DESCRIPTION (provided by applicant): Glaucoma is one of the leading causes of blindness in the world affecting 67 million people. Reduction of intraocular pressure (IOP) is the only proven treatment f ...

    STTRPhase I2012Department of Health and Human Services

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government